The Evolution of Issue Interpretation within Organizational Fields: Framing Trajectories and Field Settlement
Authors: Litrico, J.B., David, R.
Publication: Academy of Management Journal
Why Valeant Pharmaceuticals International’s new CEO may signal a shift from ‘disruptor’ to ‘plain vanilla’
Less than a year ago Valeant Pharmaceuticals International Inc.’s CEO Michael Pearson represented a disruption to big pharma by coming from outside the industry, using aggressive acquisitions and strategic business tactics to grow the company to a global giant.
Now the company has hired Joseph Papa as the new CEO, a 35-year pharmaceutical industry veteran with a history of taking a balanced approach to business. If the past few months of Pearson’s tenure can be described as rocky road, Papa could help bring a new flavour to Valeant.
Up high in the air inside the Cirque du Soleil headquarters, trained staff step gingerly on taut metal wires.
… “The famous line from Guy was, ‘We’re a private company. That gives us the freedom to grow, as we didn’t have pressure to make quarterly earnings.’ I think that’s kind of gone now,” says Robert David, professor of strategic management at McGill, who has followed the company from its early days.
Authors: David Strang, Robert J. David, and Saeed Akhlaghpour
The Social Business Academia Report 2014 gives a comprehensive overview about many of the social business initiatives that take place at universities around the world. Social businesses aim to solve social problems in a financially self-sustainable way.
... Robert J. David is Associate Professor of Strategy & Organization and the Cleghorn Faculty Scholar at the Desautels Faculty of Management, McGill University. He is also Director of the Centre for Strategy Studies in Organization at McGill.
"Seizing Opportunity in Emerging Fields: How Institutional Entrepreneurs Legitimated the Professional Form of Management Consulting," Organization Science
Authors: David, Robert; Sine, Wesley; Haveman, Heather
Publication: Organization Science, March/April 2013